Recruiting
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
NCT07152392
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China